KRAS and lung cancer: Consequently, there was a noticeably reduced viability of mutant-bearing lung cancer cells, as determined by CCK-8 assay, while minimizing the cross-reaction in WT KRAS gene-harboring H1975 cells (Figure S4C and S4E).